Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Company research

Septerna, Inc.

CIK 1984086Updated Nov 19, 2026

SEPN price & chart

Provider market data

Loading TradingView…

NASDAQ:SEPN on TradingView ↗

TradingView · Data may be delayed

About the company

Septerna, Inc. is a clinical-stage biotechnology company with a world-class team of GPCR experts and drug developers advancing cutting-edge science to unlock the full potential of GPCR therapies for patients with significant unmet needs. The company’s proprietary Native Complex Platform® is designed to enable new approaches to GPCR drug discovery and has led to the development of a diverse pipeline of novel oral small molecule drug candidates. Septerna is advancing programs in endocrinology, immunology and inflammation, metabolic diseases and additional therapeutic areas, both independently and with partners. For more information, please visit www.septerna.com. Septerna intends to use its Investor Relations website and LinkedIn as means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD. Accordingly, investors should monitor Septerna’s Investor Relations website and follow https://www.linkedin.com/company/septernainc on LinkedIn, in addition to following Septerna’s press releases, SEC filings, public conference calls, presentations, and webcasts.

8-K · 2026-11-09 · 0001193125-26-453547

Company description from the cited filing.

Financials

FY 2025 · USD
Revenue45,951,000USD · FY 2025
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

Net income-48,879,000USD · FY 2025
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

Operating income-68,297,000USD · FY 2025
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

Diluted EPS-1.1USD per share · FY 2025
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2025Q3 2024Q2 2026Q2 2025Q2 2024Q1 2026Q1 2025Q1 2024FY 2025FY 2024FY 2023
ASSETS
AssetsUSD606,653,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

As of 2025-09-30

174,281,000
Source

10-Q · 2024-11-20 · 0000950170-24-129274

As of 2024-09-30

566,737,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

As of 2026-06-30

415,231,000
Source

10-Q · 2025-08-11 · 0000950170-25-106551

As of 2025-06-30

—569,688,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

As of 2026-03-31

434,020,000
Source

10-Q · 2025-05-15 · 0000950170-25-072619

As of 2025-03-31

—596,187,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

As of 2025-12-31

456,554,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2024-12-31

130,867,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2023-12-31

Property, Plant and Equipment, NetUSD4,316,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

As of 2025-09-30

5,412,000
Source

10-Q · 2024-11-20 · 0000950170-24-129274

As of 2024-09-30

3,901,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

As of 2026-06-30

4,688,000
Source

10-Q · 2025-08-11 · 0000950170-25-106551

As of 2025-06-30

—4,328,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

As of 2026-03-31

5,042,000
Source

10-Q · 2025-05-15 · 0000950170-25-072619

As of 2025-03-31

—4,434,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

As of 2025-12-31

5,090,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2024-12-31

4,665,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2023-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD319,989,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

As of 2025-09-30

88,242,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

As of 2024-09-30

84,662,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

As of 2026-06-30

189,311,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

As of 2025-06-30

131,172,000
Source

10-Q · 2025-08-11 · 0000950170-25-106551

As of 2024-06-30

71,605,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

As of 2026-03-31

210,045,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

As of 2025-03-31

81,340,000
Source

10-Q · 2025-05-15 · 0000950170-25-072619

As of 2024-03-31

120,722,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

As of 2025-12-31

238,196,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2024-12-31

88,483,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2023-12-31

Accounts Receivable, after Allowance for Credit Loss, CurrentUSD8,645,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

As of 2025-09-30

210,000
Source

10-Q · 2024-11-20 · 0000950170-24-129274

As of 2024-09-30

12,160,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

As of 2026-06-30

151,000
Source

10-Q · 2025-08-11 · 0000950170-25-106551

As of 2025-06-30

—10,842,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

As of 2026-03-31

250,000
Source

10-Q · 2025-05-15 · 0000950170-25-072619

As of 2025-03-31

—10,356,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

As of 2025-12-31

171,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2024-12-31

151,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2023-12-31

Assets, CurrentUSD491,681,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

As of 2025-09-30

133,411,000
Source

10-Q · 2024-11-20 · 0000950170-24-129274

As of 2024-09-30

396,152,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

As of 2026-06-30

334,141,000
Source

10-Q · 2025-08-11 · 0000950170-25-106551

As of 2025-06-30

—368,058,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

As of 2026-03-31

342,469,000
Source

10-Q · 2025-05-15 · 0000950170-25-072619

As of 2025-03-31

—410,964,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

As of 2025-12-31

356,824,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2024-12-31

112,678,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2023-12-31

Prepaid Expense and Other Assets, CurrentUSD8,690,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

As of 2025-09-30

2,668,000
Source

10-Q · 2024-11-20 · 0000950170-24-129274

As of 2024-09-30

11,670,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

As of 2026-06-30

7,429,000
Source

10-Q · 2025-08-11 · 0000950170-25-106551

As of 2025-06-30

—9,815,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

As of 2026-03-31

6,214,000
Source

10-Q · 2025-05-15 · 0000950170-25-072619

As of 2025-03-31

—9,519,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

As of 2025-12-31

5,730,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2024-12-31

1,419,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2023-12-31

Operating Lease, Right-of-Use AssetUSD22,038,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

As of 2025-09-30

24,095,000
Source

10-Q · 2024-11-20 · 0000950170-24-129274

As of 2024-09-30

20,358,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

As of 2026-06-30

22,564,000
Source

10-Q · 2025-08-11 · 0000950170-25-106551

As of 2025-06-30

—20,933,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

As of 2026-03-31

23,085,000
Source

10-Q · 2025-05-15 · 0000950170-25-072619

As of 2025-03-31

—21,499,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

As of 2025-12-31

23,602,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2024-12-31

12,522,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2023-12-31

Other Assets, NoncurrentUSD501,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

As of 2025-09-30

3,479,000
Source

10-Q · 2024-11-20 · 0000950170-24-129274

As of 2024-09-30

1,230,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

As of 2026-06-30

300,000
Source

10-Q · 2025-08-11 · 0000950170-25-106551

As of 2025-06-30

—773,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

As of 2026-03-31

277,000
Source

10-Q · 2025-05-15 · 0000950170-25-072619

As of 2025-03-31

—816,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

As of 2025-12-31

267,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2024-12-31

97,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2023-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD217,922,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

As of 2025-09-30

37,532,000
Source

10-Q · 2024-11-20 · 0000950170-24-129274

As of 2024-09-30

180,016,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

As of 2026-06-30

37,674,000
Source

10-Q · 2025-08-11 · 0000950170-25-106551

As of 2025-06-30

—191,230,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

As of 2026-03-31

33,754,000
Source

10-Q · 2025-05-15 · 0000950170-25-072619

As of 2025-03-31

—214,261,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

As of 2025-12-31

36,507,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2024-12-31

20,026,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2023-12-31

Stockholders’ equity:
Common Stock, Value, IssuedUSD45,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

As of 2025-09-30

3,000
Source

10-Q · 2024-11-20 · 0000950170-24-129274

As of 2024-09-30

46,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

As of 2026-06-30

45,000
Source

10-Q · 2025-08-11 · 0000950170-25-106551

As of 2025-06-30

—45,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

As of 2026-03-31

44,000
Source

10-Q · 2025-05-15 · 0000950170-25-072619

As of 2025-03-31

—45,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

As of 2025-12-31

44,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2024-12-31

3,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2023-12-31

Retained Earnings (Accumulated Deficit)USD-156,515,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

As of 2025-09-30

-97,706,000
Source

10-Q · 2024-11-20 · 0000950170-24-129274

As of 2024-09-30

-188,924,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

As of 2026-06-30

-164,688,000
Source

10-Q · 2025-08-11 · 0000950170-25-106551

As of 2025-06-30

—-175,890,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

As of 2026-03-31

-139,850,000
Source

10-Q · 2025-05-15 · 0000950170-25-072619

As of 2025-03-31

—-167,253,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

As of 2025-12-31

-118,374,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2024-12-31

-46,576,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2023-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD375,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

As of 2025-09-30

176,000
Source

10-Q · 2024-11-20 · 0000950170-24-129274

As of 2024-09-30

-1,262,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

As of 2026-06-30

176,000
Source

10-Q · 2025-08-11 · 0000950170-25-106551

As of 2025-06-30

—-569,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

As of 2026-03-31

198,000
Source

10-Q · 2025-05-15 · 0000950170-25-072619

As of 2025-03-31

—617,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

As of 2025-12-31

56,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2024-12-31

0
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2023-12-31

Stockholders' Equity Attributable to ParentUSD388,731,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

As of 2025-09-30

-87,408,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

As of 2024-09-30

386,721,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

As of 2026-06-30

377,557,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

As of 2025-06-30

-67,763,000
Source

10-Q · 2025-08-11 · 0000950170-25-106551

As of 2024-06-30

378,458,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

As of 2026-03-31

-400,266,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

As of 2025-03-31

-51,963,000
Source

10-Q · 2025-05-15 · 0000950170-25-072619

As of 2024-03-31

381,926,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

As of 2025-12-31

420,047,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2024-12-31

-38,374,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2023-12-31

Additional Paid in Capital, Common StockUSD544,826,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

As of 2025-09-30

10,119,000
Source

10-Q · 2024-11-20 · 0000950170-24-129274

As of 2024-09-30

576,861,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

As of 2026-06-30

542,024,000
Source

10-Q · 2025-08-11 · 0000950170-25-106551

As of 2025-06-30

—554,872,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

As of 2026-03-31

539,874,000
Source

10-Q · 2025-05-15 · 0000950170-25-072619

As of 2025-03-31

—548,517,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

As of 2025-12-31

538,321,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2024-12-31

8,199,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2023-12-31

Liabilities and EquityUSD606,653,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

As of 2025-09-30

174,281,000
Source

10-Q · 2024-11-20 · 0000950170-24-129274

As of 2024-09-30

566,737,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

As of 2026-06-30

415,231,000
Source

10-Q · 2025-08-11 · 0000950170-25-106551

As of 2025-06-30

—569,688,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

As of 2026-03-31

434,020,000
Source

10-Q · 2025-05-15 · 0000950170-25-072619

As of 2025-03-31

—596,187,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

As of 2025-12-31

456,554,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2024-12-31

130,867,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2023-12-31

Current liabilities:
Liabilities, CurrentUSD75,282,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

As of 2025-09-30

13,231,000
Source

10-Q · 2024-11-20 · 0000950170-24-129274

As of 2024-09-30

79,316,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

As of 2026-06-30

15,127,000
Source

10-Q · 2025-08-11 · 0000950170-25-106551

As of 2025-06-30

—78,165,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

As of 2026-03-31

10,638,000
Source

10-Q · 2025-05-15 · 0000950170-25-072619

As of 2025-03-31

—86,931,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

As of 2025-12-31

12,849,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2024-12-31

6,914,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2023-12-31

Operating Lease, Liability, CurrentUSD2,117,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

As of 2025-09-30

1,116,000
Source

10-Q · 2024-11-20 · 0000950170-24-129274

As of 2024-09-30

2,409,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

As of 2026-06-30

2,026,000
Source

10-Q · 2025-08-11 · 0000950170-25-106551

As of 2025-06-30

—2,309,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

As of 2026-03-31

1,937,000
Source

10-Q · 2025-05-15 · 0000950170-25-072619

As of 2025-03-31

—2,212,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

As of 2025-12-31

1,851,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2024-12-31

0
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2023-12-31

Accounts Payable, CurrentUSD3,729,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

As of 2025-09-30

6,128,000
Source

10-Q · 2024-11-20 · 0000950170-24-129274

As of 2024-09-30

3,969,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

As of 2026-06-30

6,544,000
Source

10-Q · 2025-08-11 · 0000950170-25-106551

As of 2025-06-30

—7,464,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

As of 2026-03-31

4,349,000
Source

10-Q · 2025-05-15 · 0000950170-25-072619

As of 2025-03-31

—10,283,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

As of 2025-12-31

3,200,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2024-12-31

2,637,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2023-12-31

Operating Lease, Liability, NoncurrentUSD21,993,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

As of 2025-09-30

24,110,000
Source

10-Q · 2024-11-20 · 0000950170-24-129274

As of 2024-09-30

20,136,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

As of 2026-06-30

22,545,000
Source

10-Q · 2025-08-11 · 0000950170-25-106551

As of 2025-06-30

—20,781,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

As of 2026-03-31

23,089,000
Source

10-Q · 2025-05-15 · 0000950170-25-072619

As of 2025-03-31

—21,413,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

As of 2025-12-31

23,625,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2024-12-31

12,566,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2023-12-31

Other Liabilities, NoncurrentUSD0
Source

10-Q · 2025-11-10 · 0001193125-25-273375

As of 2025-09-30

191,000
Source

10-Q · 2024-11-20 · 0000950170-24-129274

As of 2024-09-30

521,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

As of 2026-06-30

2,000
Source

10-Q · 2025-08-11 · 0000950170-25-106551

As of 2025-06-30

—100,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

As of 2026-03-31

27,000
Source

10-Q · 2025-05-15 · 0000950170-25-072619

As of 2025-03-31

—0
Source

10-K · 2026-03-09 · 0001193125-26-098507

As of 2025-12-31

33,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2024-12-31

546,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2023-12-31

Additional Financial Items
Accrued Liabilities, CurrentUSD7,833,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

As of 2025-09-30

5,987,000
Source

10-Q · 2024-11-20 · 0000950170-24-129274

As of 2024-09-30

12,584,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

As of 2026-06-30

6,557,000
Source

10-Q · 2025-08-11 · 0000950170-25-106551

As of 2025-06-30

—8,629,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

As of 2026-03-31

4,352,000
Source

10-Q · 2025-05-15 · 0000950170-25-072619

As of 2025-03-31

—12,167,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

As of 2025-12-31

7,798,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2024-12-31

4,277,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2023-12-31

Deferred Tax Liabilities, NetUSD————————0
Source

10-K · 2026-03-09 · 0001193125-26-098507

As of 2025-12-31

0
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2024-12-31

491,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

As of 2023-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD——————-8,637,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

-21,476,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

-48,879,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

-71,798,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

4,180,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, Depletion and AmortizationUSD——400,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

400,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

400,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2026-04-01 to 2026-06-30

400,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2025-04-01 to 2025-06-30

400,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

400,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

1,600,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

1,400,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

800,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Share-based Payment Arrangement, Noncash ExpenseUSD——2,532,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

683,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

5,074,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2026-04-01 to 2026-06-30

1,806,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2025-04-01 to 2025-06-30

6,015,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

1,482,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

8,476,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

3,152,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

1,620,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts ReceivableUSD——————486,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

79,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

10,185,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

20,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

151,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Increase (Decrease) in Accounts PayableUSD——————-2,302,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

1,186,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

6,603,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

723,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

-653,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Deferred Income Tax Expense (Benefit)USD————————0
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

-491,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

491,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD——————-25,633,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

-23,343,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

110,189,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

-67,470,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

-38,723,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD——————-23,817,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

-4,874,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

-229,352,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

-160,598,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

22,122,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Payments to Acquire Property, Plant, and EquipmentUSD——————832,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

382,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

518,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

2,103,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

2,878,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD——————333,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

66,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

1,689,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

377,781,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

74,520,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——————-49,117,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

-28,151,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

-117,474,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

149,713,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

57,919,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Supplemental disclosure of cash flow information:
Income Taxes Paid, NetUSD————————0
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

232,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

75,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Additional Financial Items
Share-based Payment Arrangement, ExpenseUSD——2,532,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

683,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

5,074,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2026-04-01 to 2026-06-30

1,806,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2025-04-01 to 2025-06-30

6,015,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

1,482,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

8,476,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

3,152,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

1,620,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Gain (Loss) on Disposition of AssetsUSD——12,500,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

0
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

————12,500,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

0
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

47,625,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

General and Administrative ExpenseUSD——7,117,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

4,894,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

8,450,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2026-04-01 to 2026-06-30

6,909,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2025-04-01 to 2025-06-30

10,288,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

6,858,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

29,164,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

16,561,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

9,722,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Income Tax Expense (Benefit)USD——0
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

-136,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

973,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2026-04-01 to 2026-06-30

0
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2025-04-01 to 2025-06-30

337,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

0
Source

10-Q · 2025-05-15 · 0000950170-25-072619

2025-01-01 to 2025-03-31

12,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

-498,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

691,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Investment Income, InterestUSD——5,565,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

1,900,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

4,798,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2026-04-01 to 2026-06-30

4,165,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2025-04-01 to 2025-06-30

5,031,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

4,462,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

19,530,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

8,617,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

2,786,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Net Income (Loss) Attributable to ParentUSD——8,173,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

-20,523,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

-13,034,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2026-04-01 to 2026-06-30

-24,838,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2025-04-01 to 2025-06-30

-8,637,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

-21,476,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

-48,879,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

-71,798,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

4,180,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Net Income (Loss) Available to Common Stockholders, BasicUSD——8,173,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

-20,523,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

—————-71,798,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

567,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Nonoperating Income (Expense)USD——5,559,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

1,891,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

4,775,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2026-04-01 to 2026-06-30

4,140,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2025-04-01 to 2025-06-30

5,000,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

4,434,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

19,430,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

8,527,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

2,796,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Operating ExpensesUSD——18,881,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

22,726,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

43,582,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2026-04-01 to 2026-06-30

29,097,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2025-04-01 to 2025-06-30

39,823,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

26,129,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

114,248,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

81,898,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

-1,924,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Operating Lease, ExpenseUSD——————566,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

516,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

2,103,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

1,383,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

807,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Other Nonoperating Income (Expense)USD——-6,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

-9,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

-23,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2026-04-01 to 2026-06-30

-25,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2025-04-01 to 2025-06-30

-31,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

-28,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

-100,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

-90,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

10,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Proceeds from Stock Options ExercisedUSD——————333,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

66,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

973,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

52,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

0
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Depreciation, Depletion and Amortization, Nonproduction———————
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

—
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

———
Marketable Securities, Unrealized Gain (Loss)———
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

—
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

——
Source

10-Q · 2025-08-11 · 0000950170-25-106551

2025-04-01 to 2025-06-30

—————

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023
Total RevenueUSD——21,495,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

176,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

26,746,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2026-04-01 to 2026-06-30

119,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2025-04-01 to 2025-06-30

26,523,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

219,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

45,951,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

1,075,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

151,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Operating Income (Loss)USD——2,614,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

-22,550,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

-16,836,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2026-04-01 to 2026-06-30

-28,978,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2025-04-01 to 2025-06-30

-13,300,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

-25,910,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

-68,297,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

-80,823,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

2,075,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Other Nonoperating Income (Expense)USD——-6,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

-9,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

-23,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2026-04-01 to 2026-06-30

-25,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2025-04-01 to 2025-06-30

-31,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

-28,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

-100,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

-90,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

10,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD——8,173,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

-20,659,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

-12,061,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2026-04-01 to 2026-06-30

-24,838,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2025-04-01 to 2025-06-30

-8,300,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

-21,476,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

-48,867,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

-72,296,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

4,871,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Income Tax Expense (Benefit)USD——0
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

-136,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

973,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2026-04-01 to 2026-06-30

0
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2025-04-01 to 2025-06-30

337,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

0
Source

10-Q · 2025-05-15 · 0000950170-25-072619

2025-01-01 to 2025-03-31

12,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

-498,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

691,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Net Income (Loss) Attributable to ParentUSD——8,173,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

-20,523,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

-13,034,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2026-04-01 to 2026-06-30

-24,838,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2025-04-01 to 2025-06-30

-8,637,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

-21,476,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

-48,879,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

-71,798,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

4,180,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Earnings Per Share, BasicUSD per share——0.18
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

-8.4
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

-0.29
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2026-04-01 to 2026-06-30

-0.56
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2025-04-01 to 2025-06-30

-0.19
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

-0.49
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

-1.1
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

-7.26
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

0.29
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Earnings Per Share, DilutedUSD per share——0.18
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

-8.4
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

-0.29
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2026-04-01 to 2026-06-30

-0.56
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2025-04-01 to 2025-06-30

-0.19
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

-0.49
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

-1.1
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

-7.26
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

0.29
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Weighted Average Number of Shares Outstanding, Basicshares——44,343,085
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

2,443,678
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

45,040,075
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2026-04-01 to 2026-06-30

44,165,168
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2025-04-01 to 2025-06-30

44,758,800
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

43,937,410
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

44,258,338
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

9,891,126
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

1,928,586
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares——45,602,099
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

2,443,678
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

45,040,075
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2026-04-01 to 2026-06-30

44,165,168
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2025-04-01 to 2025-06-30

44,758,800
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

43,937,410
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

44,258,338
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

9,891,126
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

2,177,124
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Additional Financial Items
Current Income Tax Expense (Benefit)USD————————12,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

-7,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

200,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Depreciation, Depletion and Amortization, NonproductionUSD——————421,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

397,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

1,604,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

1,401,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

848,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

General and Administrative ExpenseUSD——7,117,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

4,894,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

8,450,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2026-04-01 to 2026-06-30

6,909,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2025-04-01 to 2025-06-30

10,288,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

6,858,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

29,164,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

16,561,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

9,722,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Investment Income, InterestUSD——5,565,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

1,900,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

4,798,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2026-04-01 to 2026-06-30

4,165,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2025-04-01 to 2025-06-30

5,031,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

4,462,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

19,530,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

8,617,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

2,786,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Net Income (Loss) Available to Common Stockholders, BasicUSD——8,173,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

-20,523,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

—————-71,798,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

567,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Nonoperating Income (Expense)USD——5,559,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

1,891,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

4,775,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2026-04-01 to 2026-06-30

4,140,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2025-04-01 to 2025-06-30

5,000,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

4,434,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

19,430,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

8,527,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

2,796,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Operating ExpensesUSD——18,881,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

22,726,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

43,582,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2026-04-01 to 2026-06-30

29,097,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2025-04-01 to 2025-06-30

39,823,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

26,129,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

114,248,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

81,898,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

-1,924,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Operating Lease, ExpenseUSD——————566,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

516,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

2,103,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

1,383,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

807,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Research and Development ExpenseUSD——24,264,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2025-07-01 to 2025-09-30

17,832,000
Source

10-Q · 2025-11-10 · 0001193125-25-273375

2024-07-01 to 2024-09-30

35,132,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2026-04-01 to 2026-06-30

22,188,000
Source

10-Q · 2026-08-10 · 0001193125-26-342353

2025-04-01 to 2025-06-30

29,535,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2026-01-01 to 2026-03-31

19,271,000
Source

10-Q · 2026-05-11 · 0001193125-26-216759

2025-01-01 to 2025-03-31

97,584,000
Source

10-K · 2026-03-09 · 0001193125-26-098507

2025-01-01 to 2025-12-31

65,337,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2024-01-01 to 2024-12-31

35,979,000
Source

10-K · 2025-03-27 · 0000950170-25-045745

2023-01-01 to 2023-12-31

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

sepn-ex99_1.htm · 8-K · 2026-11-09

Exhibit 99.1 Septerna Highlights Business Progress and Reports Third Quarter 2026 Financial Results Phase 1 Clinical Trial for PTH1R Agonist SEP-479 Ongoing; SAD / MAD Data Expected in Q1 2027 Plans to Initiate Phase 1 Clinical Trial of Newly Selected Oral TSHR NAM Development Candidate SEP-204 in Q1 2027 Cash Position of $565.2 Million Expected to Support Operating Plans at Least into mid-2029 SOUTH SAN FRANCISCO, Calif. - November 09, 2026 - Septerna, Inc. (Nasdaq: SEPN), a clinical-stage…

8-K · 2026-11-09 · 0001193125-26-453547

Read attachment ↗
d382300dex991.htm · 8-K · 2026-11-04

Exhibit 99.1 Septerna Announces Selection of SEP-204 as Development Candidate for Graves’ Disease and TED and Reports Preclinical Data at the 2026 American Thyroid Association Annual Meeting Potent, selective TSHR NAM with pre-clinical activity demonstrated across biochemical, thyroid and ocular endpoints Favorable PK profile anticipated to support once-daily oral dosing in humans Phase 1 clinical trial initiation planned for the first quarter of 2027 SOUTH SAN FRANCISCO, Calif. - November …

8-K · 2026-11-04 · 0001193125-26-446260

Read attachment ↗
d382300dex992.htm · 8-K · 2026-11-04

Exhibit 99.2 Pioneering a New Era of GPCR Drug Discovery Corporate Presentation November 2026 Nasdaq: SEPN © 2026 SEPTERNA Forward-Looking Statements This presentation contains express or implied forward‐ looking statements of Septerna, Inc. (the “Company,” “we,” or “our”) within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All statements other than statements of historical facts contained in this presentation, including statements regarding our business stra…

8-K · 2026-11-04 · 0001193125-26-446260

Read attachment ↗
d172697dex991.htm · 8-K · 2026-08-25

EX-99.1 2 d172697dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer SOUTH SAN FRANCISCO, Calif. - August 25, 2026 - Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced the appointment of Rajiv Patni, M.D., as Chief Medical Officer. Dr. Patni is a physician-scientist and accomplished biopharmaceutical executive with …

8-K · 2026-08-25 · 0001193125-26-364210

Read attachment ↗
sepn-ex99_1.htm · 8-K · 2026-08-10

EX-99.1 2 sepn-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results Phase 1 Clinical Trial Ongoing for SEP-479, an Oral Small Molecule PTH1R Agonist SEP-479 Observed Clinical Pharmacokinetic Profile Supports Once-Daily Dosing; SAD / MAD Data Expected in Q1 2027 Cash Position of $516.5 Million Expected to Support Operating Plans at Least into 2029 SOUTH SAN FRANCISCO, Calif. - August 10, 2026 - Septerna, Inc. (Na…

8-K · 2026-08-10 · 0001193125-26-342328

Read attachment ↗
sepn-ex99_1.htm · 8-K · 2026-05-11

EX-99.1 2 sepn-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Septerna Highlights Business Progress and Reports First Quarter 2026 Financial Results Compelling Phase 1 Data for SEP-631 (MRGPRX2 NAM) in Healthy Volunteers Support Phase 2b Development, Initially in Chronic Spontaneous Urticaria (CSU) in Second Half of 2026 Phase 1 Clinical Trial Initiated for SEP-479, Oral Small Molecule PTH1R Agonist for Hypoparathyroidism Cash Position of $522.1 Million Expected to Support Operating Plans at …

8-K · 2026-05-11 · 0001193125-26-216723

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.